<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>631(8019)</volume><submitter>Murase Y</submitter><pubmed_abstract>Epigenetic reprogramming resets parental epigenetic memories and differentiates primordial germ cells (PGCs) into mitotic pro-spermatogonia or oogonia. This process ensures sexually dimorphic germ cell development for totipotency&lt;sup>1&lt;/sup>. In vitro reconstitution of epigenetic reprogramming in humans remains a fundamental challenge. Here we establish a strategy for inducing epigenetic reprogramming and differentiation of pluripotent stem-cell-derived human PGC-like cells (hPGCLCs) into mitotic pro-spermatogonia or oogonia, coupled with their extensive amplification (about >10&lt;sup>10&lt;/sup>-fold). Bone morphogenetic protein (BMP) signalling is a key driver of these processes. BMP-driven hPGCLC differentiation involves attenuation of the MAPK (ERK) pathway and both de novo and maintenance DNA methyltransferase activities, which probably promote replication-coupled, passive DNA demethylation. hPGCLCs deficient in TET1, an active DNA demethylase abundant in human germ cells&lt;sup>2,3&lt;/sup>, differentiate into extraembryonic cells, including amnion, with de-repression of key genes that bear bivalent promoters. These cells fail to fully activate genes vital for spermatogenesis and oogenesis, and their promoters remain methylated. Our study provides a framework for epigenetic reprogramming in humans and an important advance in human biology. Through the generation of abundant mitotic pro-spermatogonia and oogonia-like cells, our results also represent a milestone for human in vitro gametogenesis research and its potential translation into reproductive medicine.</pubmed_abstract><journal>Nature</journal><pagination>170-178</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11222161</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>In vitro reconstitution of epigenetic reprogramming in the human germ line.</pubmed_title><pmcid>PMC11222161</pmcid><pubmed_authors>Tsujimura T</pubmed_authors><pubmed_authors>Kitamura A</pubmed_authors><pubmed_authors>Yokogawa R</pubmed_authors><pubmed_authors>Yabuta Y</pubmed_authors><pubmed_authors>Yamamoto T</pubmed_authors><pubmed_authors>Ishihama Y</pubmed_authors><pubmed_authors>Murase Y</pubmed_authors><pubmed_authors>Katou Y</pubmed_authors><pubmed_authors>Hu B</pubmed_authors><pubmed_authors>Saitou M</pubmed_authors><pubmed_authors>Puangsricharoen P</pubmed_authors><pubmed_authors>Mizuta K</pubmed_authors><pubmed_authors>Yamashiro C</pubmed_authors><pubmed_authors>Mizuyama M</pubmed_authors><pubmed_authors>Ogata K</pubmed_authors><pubmed_authors>Nagano M</pubmed_authors></additional><is_claimable>false</is_claimable><name>In vitro reconstitution of epigenetic reprogramming in the human germ line.</name><description>Epigenetic reprogramming resets parental epigenetic memories and differentiates primordial germ cells (PGCs) into mitotic pro-spermatogonia or oogonia. This process ensures sexually dimorphic germ cell development for totipotency&lt;sup>1&lt;/sup>. In vitro reconstitution of epigenetic reprogramming in humans remains a fundamental challenge. Here we establish a strategy for inducing epigenetic reprogramming and differentiation of pluripotent stem-cell-derived human PGC-like cells (hPGCLCs) into mitotic pro-spermatogonia or oogonia, coupled with their extensive amplification (about >10&lt;sup>10&lt;/sup>-fold). Bone morphogenetic protein (BMP) signalling is a key driver of these processes. BMP-driven hPGCLC differentiation involves attenuation of the MAPK (ERK) pathway and both de novo and maintenance DNA methyltransferase activities, which probably promote replication-coupled, passive DNA demethylation. hPGCLCs deficient in TET1, an active DNA demethylase abundant in human germ cells&lt;sup>2,3&lt;/sup>, differentiate into extraembryonic cells, including amnion, with de-repression of key genes that bear bivalent promoters. These cells fail to fully activate genes vital for spermatogenesis and oogenesis, and their promoters remain methylated. Our study provides a framework for epigenetic reprogramming in humans and an important advance in human biology. Through the generation of abundant mitotic pro-spermatogonia and oogonia-like cells, our results also represent a milestone for human in vitro gametogenesis research and its potential translation into reproductive medicine.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2024-11-14T16:56:50.736Z</modification><creation>2024-11-14T16:56:50.736Z</creation></dates><accession>S-EPMC11222161</accession><cross_references><pubmed>38768632</pubmed><doi>10.1038/s41586-024-07526-6</doi></cross_references></HashMap>